Resultats de la cerca - Polonis VR

  • Mostrar 1 - 9 resultats de 9
Refinar resultats
Llistat   Quadrícula  
  1. 1

    P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay per Alving CR, Polonis VR, Wieczorek L, Peachman K, Rao M

    Publicat 2009-10-01
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2

    Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide per Matyas GR, Jobe O, Wieczorek L, Peachman KK, Beck Z, Polonis VR, Rao M, Alving CR

    Publicat 2012-09-01
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3

    The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization per Cincotta CD, Wieczorek LM, Barrows B, Brown B, Asher L, Michael N, Marovich M, Polonis VR

    Publicat 2012-09-01
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4

    P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes per Polonis VR, Michael NL, Kappes JC, Ochsenbauer-Jambor C, Beck Z, Wieczorek L, Matyas GR, Alving CR

    Publicat 2009-10-01
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5

    P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β per Alving CR, Marovich M, Polonis VR, Asher LM, Matyas GR, Wieczorek L, Boonnak K, Peachman KK, Weaver KL, Rao M

    Publicat 2009-10-01
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6

    Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene per O'Connell RJ, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Malia J, Michael NL, Excler J, Robb ML, Kim JH

    Publicat 2012-09-01
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7

    Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults per Joachim A, Nilsson C, Aboud S, Lyamuya EF, Robb M, Marovich M, Ochsenbauer C, Wahren B, Sandström E, Biberfeld G, Ferrari G, Polonis VR

    Publicat 2012-09-01
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8

    P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays per Montefiori D, Michael NL, Ochsenbauer-Jambor C, Kappes JC, Kijak G, Wieczorek L, Thelian D, Currier J, Bryson M, Lombardi K, Brown BK, Polonis VR

    Publicat 2009-10-01
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9

    P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda per Robb ML, Michael NL, Gray R, Wawer M, Sewankambo N, Serwadda D, Kiwanuka N, Quinn T, Laeyendecker O, Wabwire-Mangen F, de Souza MS, Eller MA, Oballah P, Ouma B, Eller L, Montefiori D, Brown BK, Polonis VR

    Publicat 2009-10-01
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: